Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Changes in Equity

v3.20.4
Consolidated Statements of Changes in Equity - USD ($)
Special Voting Preferred Stock
Common
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Akerna Shareholders’ Equity
Noncontrolling Interest in Consolidated Subsidiary
Total
Balance at Jun. 30, 2018   $ 492 $ 14,563,102 $ (13,163,531) $ 1,400,063 $ 1,400,063
Balance, shares at Jun. 30, 2018   4,922,650            
Issuance of common stock   $ 110 9,999,890 10,000,000 10,000,000
Issuance of common stock, shares   1,099,376            
Issuance of common stock in connection with reverse merger   $ 388 18,878,387 18,878,775 18,878,775
Issuance of common stock in connection with reverse merger, shares   3,880,282            
Issuance of common stock for compensation in connection with reverse merger   $ 50 3,393,231 3,393,281 3,393,281
Issuance of common stock for compensation in connection with reverse merger, shares   498,073            
Stock-based compensation amortization   490,830 490,830 490,830
Common stock issued upon cashless exercise of options   $ 19 (19)        
Common stock issued upon cashless exercise of options, shares   189,365            
Net loss   (12,403,215) (12,403,215) (12,403,215)
Balance at Jun. 30, 2019   $ 1,059 47,325,421 (25,566,746) 21,759,734 21,759,734
Balance, shares at Jun. 30, 2019   10,589,746            
Amortization of stock-based compensation 161,165 161,165 161,165
Cash received in connection with exercise of warrants $ 37 4,242,417 4,242,454
Cash received in connection with exercise of warrants, shares   368,910            
Net loss (2,326,332) (2,326,332) (2,326,332)
Balance at Sep. 30, 2019   $ 1,096 51,729,003 (27,893,078) 23,837,021 23,837,021
Balance, shares at Sep. 30, 2019 10,958,656            
Balance at Jun. 30, 2019   $ 1,059 47,325,421 (25,566,746) 21,759,734 21,759,734
Balance, shares at Jun. 30, 2019   10,589,746            
Stock-based compensation amortization   1,253,234 1,253,234 1,253,234
Common stock issued upon warrant exercise   $ 37 4,247,028 4,247,065 4,247,065
Common stock issued upon warrant exercise, shares   369,311            
Common stock issued in business combinations   $ 230 20,081,236 20,081,466 20,081,466
Common stock issued in business combinations, shares   2,299,650            
Noncontrolling interest in acquired subsidiary       5,554,011 5,554,011
Forfeitures of restricted shares   $ (5) 5        
Forfeitures of restricted shares, shares   (54,901)            
Change in fair value of Convertible Notes   63,000 63,000 63,000
Net loss       (15,534,345) (15,534,345) (849,759) (16,384,104)
Balance at Jun. 30, 2020 $ 1,321 72,906,924 63,000 (41,101,091) 31,870,154 4,704,252 31,870,154
Balance, shares at Jun. 30, 2020   13,203,806            
Special voting preferred stock issued in business combination 25,203,490 25,203,490 25,203,490
Conversion of Exchangeable Shares to common stock (4,798,271) $ 63 4,798,208
Conversion of Exchangeable Shares to common stock, shares   627,225            
Acquisition of noncontrolling interest $ 80 4,695,357 4,695,437 (4,695,437)
Acquisition of noncontrolling interest, shares   800,000            
Amortization of stock-based compensation 764,351 764,351 764,351
Restricted stock unit vesting
Restricted stock unit vesting, shares   3,025            
Issuance of common stock in connection with reverse merger               25,200,000
Change in fair value of Convertible Notes (70,000) (70,000) (70,000)
Net loss (4,741,876) (4,741,876) (8,815) (4,750,691)
Balance at Sep. 30, 2020 $ 20,405,219 $ 1,464 $ 83,164,840 $ (7,000) $ (45,842,967) $ 57,721,556 $ 57,721,556
Balance, shares at Sep. 30, 2020   14,634,056